On September 22, the U.S. Food and Drug Administration added ileus—which can result in intestinal blockage—as a possible adverse event to the Ozempic label. (Photo by Jaap Arriens/NurPhoto via Getty ...
The U.S. Food and Drug Administration (FDA) updated the label for Ozempic, a type 2 diabetes drug that is often used for weight loss, to now note the potential side effect of intestinal blockage. In a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback